ES2069150T3 - Preparacion acuosa estable. - Google Patents

Preparacion acuosa estable.

Info

Publication number
ES2069150T3
ES2069150T3 ES91114550T ES91114550T ES2069150T3 ES 2069150 T3 ES2069150 T3 ES 2069150T3 ES 91114550 T ES91114550 T ES 91114550T ES 91114550 T ES91114550 T ES 91114550T ES 2069150 T3 ES2069150 T3 ES 2069150T3
Authority
ES
Spain
Prior art keywords
acid
vitamin
water preparation
stable water
epsilon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91114550T
Other languages
English (en)
Inventor
Kazumichi Ushio
Kenichi Yoshida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senju Pharmaceutical Co Ltd
Original Assignee
Senju Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=16899290&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2069150(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Senju Pharmaceutical Co Ltd filed Critical Senju Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2069150T3 publication Critical patent/ES2069150T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

SE DESCRIBE UNA PREPARACION ACUOSA ESTABLE PARA LA ADMINISTRACION OFTALMOLOGICA TOPICA QUE CONTIENE VITAMINA A O UN DERIVADO DE LA VITAMINA A TENIENDO PROPIEDADES DE LA VITAMINA A PARA SER UTILIZADA EN EL TRATAMIENTO DEL SINDROME DEL OJO SECO, CARACTERIZADA PORQUE CONTIENE UN COMPONENTE DE AMORTIGUAMIENTO SELECCIONADO ENTRE LOS DE UN GRUPO QUE CONSTA DE ACIDO FOSFORICO, ACIDO BORICO, ACIDO CITRICO, ACIDO GLUTAMICO, ACIDO E-AMINOCAPROICO Y LAS SALES METALICAS ALCALINAS DE LOS ANTERIORES, UN REVESTIDOR NO-IONICO Y UN AGENTE QUELANTE, SU ACIDEZ ESTA AJUSTADA ENTRE UN PH DE 5 A 8 Y ESTA CONTENIDA EN UN RECIPIENTE HERMETICO HECHO DE POLIPROPILENO O TEREFTALATO DE POLIPROPILENO.
ES91114550T 1990-08-30 1991-08-29 Preparacion acuosa estable. Expired - Lifetime ES2069150T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP22988890 1990-08-30

Publications (1)

Publication Number Publication Date
ES2069150T3 true ES2069150T3 (es) 1995-05-01

Family

ID=16899290

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91114550T Expired - Lifetime ES2069150T3 (es) 1990-08-30 1991-08-29 Preparacion acuosa estable.

Country Status (9)

Country Link
US (1) US5185372A (es)
EP (1) EP0473159B1 (es)
JP (1) JP3256997B2 (es)
AT (1) ATE119387T1 (es)
CA (1) CA2049822C (es)
DE (1) DE69107932T2 (es)
DK (1) DK0473159T3 (es)
ES (1) ES2069150T3 (es)
GR (1) GR3015340T3 (es)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830508A (en) 1992-08-06 1998-11-03 Deo Corporation Composition for treating dry eye
US5366739A (en) * 1992-08-06 1994-11-22 Deo Corporation Method of ophthalmic drug delivery
TW252974B (es) * 1993-03-23 1995-08-01 Takeda Dharm Industry Co Ltd
US20020173547A1 (en) 1994-03-22 2002-11-21 Jones Christopher Buchan Pharmaceuticals compositions
US6011062A (en) * 1994-12-22 2000-01-04 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
US5631287A (en) * 1994-12-22 1997-05-20 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
US5706542A (en) * 1995-06-27 1998-01-13 Okada; Eiji Electrically driven toothbrush
US5617602A (en) * 1995-06-27 1997-04-08 Okada; Eiji Motor-driven toothbrush
JPH09124484A (ja) * 1995-10-27 1997-05-13 Schering Purau Kk 点眼剤
CA2288726C (en) * 1997-04-25 2008-04-01 Schering-Plough Kabushiki Kaisha Eyedrops containing a loratadine metabolite
BR9906597A (pt) * 1998-07-14 2000-07-18 Alcon Lab Inc Produto de prostaglandina
US6235781B1 (en) 1998-07-14 2001-05-22 Alcon Laboratories, Inc. Prostaglandin product
US6291519B1 (en) * 1998-10-14 2001-09-18 Novartis Ag Method of preventing damage to eye tissue
WO2001012225A1 (en) * 1999-08-10 2001-02-22 Santen Pharmaceutical Co., Ltd. Water channel opener compositions and medicinal compositions for ophthalmic use
JP4880808B2 (ja) * 1999-11-15 2012-02-22 久光製薬株式会社 人工涙液型点眼剤組成物
WO2002022106A2 (en) * 2000-09-14 2002-03-21 Novartis Ag Stable ophthalmic preparation
JP4849288B2 (ja) * 2000-09-29 2012-01-11 ライオン株式会社 点眼剤及び涙液膜の安定化剤
US6774100B2 (en) 2000-12-06 2004-08-10 Imaginative Research Associates, Inc. Anhydrous creams, lotions and gels
US6462025B2 (en) 2000-12-12 2002-10-08 Imaginative Research Associates, Inc. Antibiotic/benzoyl peroxide dispenser
US20060189552A1 (en) * 2000-12-12 2006-08-24 Mohan Vishnupad Dispenser for dispensing three or more actives
US7060732B2 (en) * 2000-12-12 2006-06-13 Imaginative Research Associates, Inc. Antibiotic/benzoyl peroxide dispenser
WO2002049613A2 (en) * 2000-12-19 2002-06-27 Bausch & Lomb Incorporated Method for enhancing integrity of epithelium using retinoic acid
TW586946B (en) * 2000-12-22 2004-05-11 Novartis Ag Process to improve stability
AU2002228449B2 (en) * 2001-01-09 2007-12-06 Louis Johan Wagenaar Procedure and composition of treatment and/or care of the eye
US20030165546A1 (en) * 2002-03-04 2003-09-04 The Procter & Gamble Company Stable personal care compositions containing a retinoid
US6984628B2 (en) * 2003-07-15 2006-01-10 Allergan, Inc. Ophthalmic compositions comprising trefoil factor family peptides
DE10355715A1 (de) * 2003-11-26 2005-06-16 Beiersdorf Ag Wirkstoffkombinationen Kreatin und/oder Kreatinderivaten und/oder Kreatinin und/oder Kreatininderivaten und einer wirksamen Menge an Retinoiden, insbesondere Retinol bzw. Retinylpalmitat und Zubereitungen, solche Wirkstoffkombinationen enthaltend
US9161905B2 (en) * 2005-01-12 2015-10-20 Ocular Research Of Boston, Inc. Dry eye treatment
DE102005012176A1 (de) * 2005-03-15 2006-09-28 Zarrin Anna Buchheim Gerät zur reinigenden Behandlung der Augenlider
US20070249727A1 (en) 2006-04-21 2007-10-25 The Proctor & Gamble Company Compositions and kits useful for treatment of respiratory illness
US10022339B2 (en) 2006-04-21 2018-07-17 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness
WO2008052037A2 (en) * 2006-10-24 2008-05-02 Alcon Research, Ltd. Packaging materials for formulations containing 2-pyrrolidone derivatives
US9034843B2 (en) * 2007-09-14 2015-05-19 Rohto Pharmaceutical Co., Ltd. Ophthalmic composition
GB2471304B (en) 2009-06-24 2013-12-11 Oval Medical Technologies Ltd A pre-filled syringe or autoinjector
GB2471726B (en) * 2009-07-10 2013-09-11 Oval Medical Technologies Ltd A pre-filled syringe including an oxygen absorber
JP5518608B2 (ja) * 2010-07-09 2014-06-11 ロート製薬株式会社 粘膜適用液状組成物
US20130281390A1 (en) * 2010-12-29 2013-10-24 Kurt E. Brubaker Method for treating dry eye
JP2012006962A (ja) * 2011-08-22 2012-01-12 Lion Corp 眼科用組成物
JP5345743B1 (ja) * 2012-02-27 2013-11-20 ロート製薬株式会社 眼科用組成物キット
WO2016172712A2 (en) * 2015-04-23 2016-10-27 Sydnexis, Inc. Ophthalmic composition
KR102887267B1 (ko) 2018-11-26 2025-11-17 오파닉스 게엠베하 수성 소아용 레티놀 제형
EP4013461A4 (en) * 2019-08-18 2023-08-23 IVIEW Therapeutics, Inc. STABLE PHARMACEUTICAL ARTICLES CONTAINING DILUTE FORMULATIONS OF POVIDONE-IODINE

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4199567A (en) * 1979-01-02 1980-04-22 Burton, Parsons & Company, Inc. Method for imparting freeze stability to chlorhexidine-containing medicaments
US5032392A (en) * 1986-09-04 1991-07-16 Vision Pharmaceuticals Aqueous ophthalmic solutions for the treatment of dryness and/or irritation of human or animal eyes
US4966773A (en) * 1986-11-25 1990-10-30 Alcon Laboratories, Inc. Topical ophthalmic compositions containing microfine retinoid particles

Also Published As

Publication number Publication date
JPH054918A (ja) 1993-01-14
DE69107932D1 (de) 1995-04-13
JP3256997B2 (ja) 2002-02-18
ATE119387T1 (de) 1995-03-15
CA2049822A1 (en) 1992-03-01
EP0473159A1 (en) 1992-03-04
DE69107932T2 (de) 1995-07-27
US5185372A (en) 1993-02-09
EP0473159B1 (en) 1995-03-08
DK0473159T3 (da) 1995-05-22
GR3015340T3 (en) 1995-06-30
CA2049822C (en) 2001-07-24

Similar Documents

Publication Publication Date Title
ES2069150T3 (es) Preparacion acuosa estable.
DE3569836D1 (en) Disinfecting method and compositions
ATE134377T1 (de) Stabile salze von 4''-desoxy-4''-epimethylamino- avermectin-bla/blb
EP0359574A3 (en) Aqueous antimicrobial solutions for contact lens care
ES2103987T3 (es) Usos de acidos grasos alfa-hidroxilados.
NO178687C (no) Fremgangsmåte for fremstilling av forenlige, lagringsstabile erythropoietinpreparater
DE69131145D1 (de) Reinigung und Desinfektion von Kontaktlinsen mittels Kombinationen von polymeren quaternären Ammoniumverbindungen und Enzymen
GB1231541A (es)
KR950702419A (ko) 오메프라졸 및 그의 동족체를 함유하는 주사제 및 주사제 키트(injection and injection kit containing omeprazole and its analogs)
EP0251369A3 (en) Pharmaceutical compositions endowed with sequestering activity for the biliary acids, containing colestyramin as their active principle, and process for preparing them
DK0472327T3 (da) Præparat på form af øjendråber
IL84911A (en) Processes for the preparation of collagen products, and pharmaceutical compositions containing the same
ATE259656T1 (de) Immunoglobulin enthaltende zusammensetzung
TW266154B (es)
AU1950683A (en) Protracted release microbiocidal articles
DE59410151D1 (de) Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe
NO175406C (no) Fremgangsmåte ved fremstilling av piroxam i vandig opplösning
DK0490549T3 (da) Stabilisering af calcitonin-holdige farmaceutiske præparater
ATE42680T1 (de) Verfahren und ''kit'' zur desinfektion von kontaktlinsen.
KR930000096A (ko) 제제
TW372193B (en) Novel pharmaceutical composition for the preparation of a stable powder containing an association of acetylsalicylic acid and metoclopramide as the active ingredient
NO940160D0 (no) Oeyepreparater inneholdende oxicam eller oxicamderivater
DE3863859D1 (de) Stabile, injizierbare loesungen von salzen von vincristin.
MY103079A (en) New ophtalmological composition of matter
KR930001903A (ko) 유비데카레논 경구용 수용액 제제

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 473159

Country of ref document: ES